一个全面的方法来开发一种针对Mycobacterium结核病的多表位疫苗:从in silico设计到in vitro免疫评估

Fan Jiang1,2,3,4, Yong Han2, Yinping Liu1

  • 1Beijing Key Laboratory of New Techniques of Tuberculosis Diagnosis and Treatment, Senior Department of Tuberculosis, The Eighth Medical Center of PLA General Hospital, Beijing, China.

Frontiers in immunology
|November 29, 2023
PubMed
概括

一种新的多表位疫苗 (MEV) 候选剂,PP13138R,显示出对预防结核病 (TB) 的希望. 这种新型候选疫苗在临床前评估中表现出强大的免疫性和有利的特征.

相关概念视频